Book Online
Make a Booking

Adult RSV Clinical Trial

ConquerRSV Trial - Based in Brisbane

The purpose of this clinical trial is to assess the safety and efficacy of an investigational vaccine (a vaccine not yet approved by a country’s drug regulatory agency) aimed at preventing RSV infection in women and men over 60.

OVERVIEW

RSV is a common respiratory virus that infects the lungs and breathing passages. People most frequently associate RSV with the risk it brings to young children, but not many know the high risk it poses for older adults.

INVESTIGATIONAL TREATMENT

There are currently no approved treatments or vaccines for RSV. Moderna is sponsoring a clinical trial for mRNA-1345, an investigational vaccine. Moderna is studying this vaccine to understand whether it can help your body’s immune system protect against RSV.

WHAT’S INVOLVED?

The total length of participation in this clinical trial is approximately 2 years (25 months). It includes up to 8 trial visits and 20 brief communications (via telephone).

Reimbursement for travel and your time will be provided, and all study doctor visits will be free of charge.

ELIGIBILITY

PRINCIPAL INVESTIGATOR

CONTACT US

Contact Details